Empowering organisations with the best available evidence to make informed decisions
The strength of Prospection’s analytical tactics and machine learning algorithms is shown in the value of the data we deliver. We analyse longitudinal patient data and commercially available data to leverage the deep patient insights to provide rich, evidence-based support for our clients.
Prospection powered data is rigorous, applicable, and demonstrably useful in modern medical research.
We give our pharma clients and doctors the confidence to make decisions backed by real-world evidence.
The data we pull gives deep consumer insights, finding optimisations for treatments.
Through decisions support, Prospection helps clients to:
Predictive Modelling for Prostate Cancer
For the betterment of patient outcomes, Prospection R&D designed a predictive algorithm to identify prostate cancer patients at risk of developing metastatic disease. Through strategic analysis of longitudinal patient and pathology data, Prospection was able to stratify patient cohorts by progression rates. From there, a predictive model was created with an Accuracy Score (ROC) of 0.901, helping patients to get the right treatment earlier.
Drug Utilisation Modelling for Pricing & Reimbursement Review
Our pharma client, headquartered in Japan, came to Prospection with a problem: their reimbursement deed was due for renegotiation with the payor, but higher than forecasted drug claims were putting pressure on the pricing agreement. By analysing historical claims data across varied patient demographics, Prospection provided a thorough Drug Utilisation model that our client was then able to use as real evidence during their pricing negotiations.